Patent CA764897A successfully refreshed from Google Patents.
Patent EP0100382A1 successfully refreshed from Google Patents.
EP0100382A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
An intravenous nutrient
Assignee: Unitika Ltd
•
Filing: 1982-08-02
•
Granted: —
•
Expires: 2002-08-02
Abstract
Abstract The present invention is an intravenous nutrient which contains a fatty acid ester of carbohydrate and water. The nutrient fluid contains a carbohydrate component and a fat component. has an excellent stability in solution, and is used in nutrient fluid therapy for individuals who cannot take food orally. The nutrient fluid is especially suitable as a high calorie intravenous nutrient.
Inventors
- 👤 Yabushita Yasunori
- 👤 Takagi Kunihiko
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-09 05:55
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7004; C; C07; C07H; C07H13/00; C07H13/02; C07H13/04; C07H13/06
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
12 words
An intravenous nutrient, comprising: a fatty acid ester of carbohydrate; and water.
Claim 2
Dependent Claim
12 words
An intravenous nutrient, comprising: a fatty acid ester of carbohydrate; and water.
Claim 3
Dependent Claim
27 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between a carbohydrate and a long-chain fatty acid.
Claim 4
Dependent Claim
26 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between a monosaccharide and a fatty acid.
Claim 5
Dependent Claim
27 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between a monosaccharide and a long-chain fatty acid-
Claim 6
Dependent Claim
26 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between an oligosaccharide and a fatty acid.
Claim 7
Dependent Claim
27 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between an oligosaccharide and a long-chain fatty acid.
Claim 8
Dependent Claim
28 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between carbohydrate and a plurality of long-chain fatty acids.
Claim 9
Dependent Claim
28 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between a monosaccharide and a plurality of fatty acids.
Claim 10
Dependent Claim
29 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between a monosaccharide and a plurality of long-chain fatty acids.
Claim 11
Dependent Claim
28 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between an oligosaccharide and a plurality of fatty acids.
Claim 12
Dependent Claim
29 words
The intravenous nutrient according to Claim 1, wherein the fatty acid ester of carbohydrate is produced by a reaction between an oligosaccharide and a plurality of long-chain fatty acids.
Claim 13
Dependent Claim
25 words
The intravenous nutrient as claimed in Claim 2, 4, 6, 7, 9 or 11, wherein the long-chain fatty acid is a long-chain unsaturated fatty acid.
Claim 14
Dependent Claim
23 words
The intravenous nutrient as claimed in Claim 3, 4, 8 or 9, wherein the monosaccharide is selected from glucose, fructose, xylitol and sorbitol.
Claim 15
Dependent Claim
36 words
The intravenous nutrient as claimed in Claim 5, 6, 10 or 11, wherein the oligosaccharide is a substance comprising 2 to 6 sugar unit residues as a structural monomer and having at least one glucopyranose residue.
Claim 16
Dependent Claim
23 words
The intravenous nutrient as claimed in Claim 5, 6, 10, 11 or 14, wherein the oligosaccharide is selected from maltose, sucrose and lactose.
Claim 17
Dependent Claim
29 words
The intravenous nutrient as claimed in Claim 2, 4, 6, 7, 9 or 11, wherein the long-chain fatty acid is selected from oleic acid, linoleic acid and linolenic acid.
Claim 18
Dependent Claim
40 words
The intravenous nutrient according to Claim 1, which contains the fatty acid ester of carbohydrate in an amount of from about 0.001 to about 80 wt% relative to the total amount of the fatty acid ester of carbohydrate and water.
Claim 19
Dependent Claim
38 words
The intravenous nutrient according to Claim 1, which contains the fatty acid ester of carbohydrate in an amount of from 0.1 to 60 wt% relative to the total amount of the fatty acid ester of carbohydrate and water.
Claim 20
Dependent Claim
23 words
A composition comprising a fatty acid ester of carbohydrate; and water, for intravenous feeding as a nutrient into a human or animal body.
Claim 21
Dependent Claim
23 words
A composition comprising a fatty acid ester of carbohydrate; and water, for intravenous feeding as a nutrient into a human or animal body.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.